117 related articles for article (PubMed ID: 22980714)
21. Differences in the identification process for new and emerging health technologies: analysis of the EuroScan database.
Ibargoyen-Roteta N; Gutierrez-Ibarluzea I; Benguria-Arrate G; Galnares-Cordero L; Asua J
Int J Technol Assess Health Care; 2009 Jul; 25(3):367-73. PubMed ID: 19619356
[TBL] [Abstract][Full Text] [Related]
22. Early awareness and alert activities in Latin America: current situation in four countries.
Pichon-Riviere A; Silva Elias FT; Rivero VG; Vaca CP
Int J Technol Assess Health Care; 2012 Jul; 28(3):315-20. PubMed ID: 22980710
[TBL] [Abstract][Full Text] [Related]
23. Selection of new health technologies for assessment aimed at informing decision making: A survey among horizon scanning systems.
Douw K; Vondeling H
Int J Technol Assess Health Care; 2006; 22(2):177-83. PubMed ID: 16571193
[TBL] [Abstract][Full Text] [Related]
24. Sustainability of healthcare systems in Asia: exploring the roles of horizon scanning and reassessment in the health technology assessment landscape.
Mundy L; Trowman R; Kearney B
Int J Technol Assess Health Care; 2020 Jun; 36(3):262-269. PubMed ID: 32389130
[TBL] [Abstract][Full Text] [Related]
25. Health technology assessment for radiologists: basic principles and evaluation framework.
Lim ME; O'Reilly D; Tarride JE; Burke N; Ferrusi IL; Campbell K; Goeree R
J Am Coll Radiol; 2009 May; 6(5):299-306. PubMed ID: 19394570
[TBL] [Abstract][Full Text] [Related]
26. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
27. [Innovation in health care: the role of HTA in the introduction of new technologies].
Bührlen B
Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):703-8. PubMed ID: 21147431
[TBL] [Abstract][Full Text] [Related]
28. The role of surgeons in identifying emerging technologies for health technology assessment.
Stafinski T; Topfer LA; Zakariasen K; Menon D
Can J Surg; 2010 Apr; 53(2):86-92. PubMed ID: 20334740
[TBL] [Abstract][Full Text] [Related]
29. [The implementation of innovative medical technologies: biological pharmaceuticals for the treatment of psoriasis--a case study].
Tal O; Lomnicky Y
Harefuah; 2012 Jun; 151(6):368-71, 376. PubMed ID: 22991870
[TBL] [Abstract][Full Text] [Related]
30. Comparison of statistical analysis methods for object case best-worst scaling.
Cheung KL; Mayer S; Simon J; de Vries H; Evers SMAA; Kremer IEH; Hiligsmann M
J Med Econ; 2019 Jun; 22(6):509-515. PubMed ID: 30482068
[No Abstract] [Full Text] [Related]
31. Conditionally funded field evaluations and practical trial design within a health technology assessment framework.
Bowen JM; Patterson LL; O'Reilly D; Hopkins RB; Blackhouse G; Burke N; Xie F; Tarride JE; Goeree R
J Am Coll Radiol; 2009 May; 6(5):324-31. PubMed ID: 19394573
[TBL] [Abstract][Full Text] [Related]
32. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
[TBL] [Abstract][Full Text] [Related]
33. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
Marquardt JU; Galle PR; Teufel A
J Hepatol; 2012 Jan; 56(1):267-75. PubMed ID: 21782758
[TBL] [Abstract][Full Text] [Related]
34. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
35. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
[TBL] [Abstract][Full Text] [Related]
36. Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology.
Fattore G; Maniadakis N; Mantovani LG; Boriani G
Europace; 2011 May; 13 Suppl 2():ii49-53. PubMed ID: 21518750
[TBL] [Abstract][Full Text] [Related]
37. Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic variations.
Pawlik TM; Esnaola NF; Vauthey JN
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S74-80. PubMed ID: 14762844
[TBL] [Abstract][Full Text] [Related]
38. Can we reliably benchmark health technology assessment organizations?
Drummond M; Neumann P; Jönsson B; Luce B; Schwartz JS; Siebert U; Sullivan SD
Int J Technol Assess Health Care; 2012 Apr; 28(2):159-65. PubMed ID: 22559758
[TBL] [Abstract][Full Text] [Related]
39. A preliminary survey on the influence of rapid health technology assessments.
Hailey D
Int J Technol Assess Health Care; 2009 Jul; 25(3):415-8. PubMed ID: 19619362
[TBL] [Abstract][Full Text] [Related]
40. Information service on new and emerging health technologies: identification and prioritization processes for a European union-wide newsletter.
Wild C; Simpson S; Douw K; Geiger-Gritsch S; Mathis S; Langer T
Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():48-55. PubMed ID: 20030891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
